ZH reported, citing a May 23 report from China Daily.
Brain-computer interfaces (BCIs), once largely confined to neuroscience labs and experimental research, are increasingly moving into real-world applications in China — driven by a combination of policy support, private-sector innovation, and rapid advances in artificial intelligence and robotics.
From assistive medical devices to embodied AI systems and even commercial robotics, BCIs are beginning to evolve from niche technologies into scalable industrial products.
From Laboratory Research to Practical Use
At the Brain-Computer Science Innovation Demonstration Center in Hangzhou’s Yuhang district, the transformation is already visible.
There, a staff member from neurotechnology company BrainCo — who lost both arms — is able to write calligraphy again using an intelligent bionic hand. The device interprets neural signals and translates them into precise movements, allowing him to hold a brush and produce ink-based writing.
Behind this capability is non-invasive brain-computer interface technology developed by BrainCo, one of China’s leading neurotechnology firms.
Unlike invasive implants, non-invasive BCIs rely on external sensors to capture brain signals, making them safer and more suitable for large-scale commercial deployment.
Lower Costs, Wider Access
One of the most significant developments in China’s BCI sector is cost reduction.
According to industry figures, domestically developed intelligent bionic hands cost only one-fifth to one-seventh of comparable foreign products. This price gap has accelerated adoption across both medical and industrial markets.
Lower costs are helping BCIs move beyond elite clinical environments and into broader use cases, including rehabilitation, assistive robotics and workplace applications.
As a result, technologies that were once experimental are now being positioned as practical tools for everyday use.
Expanding from Healthcare to Embodied AI
Initially, BCI applications in China focused heavily on medical rehabilitation — particularly for patients with limb loss or neurological impairments.
However, the scope of the technology is rapidly expanding.
Companies like BrainCo report that their products are now being integrated into humanoid robots and embodied artificial intelligence systems. In these applications, BCIs and related neurotechnology components are used as part of broader human–machine interaction systems.
According to the company’s leadership, their products are already being used across more than 35 countries and regions, reflecting growing international demand for Chinese-developed neurotechnology solutions.
This shift marks an important transition: from assistive medical devices to foundational components in advanced robotics and AI systems.
Policy Support Accelerates Commercialization
China’s push into brain-computer interfaces is closely linked to national industrial policy.
The 15th Five-Year Plan (2026–2030) explicitly lists BCIs among six key future industries, signaling strong government support for their development and commercialization.
This policy framework reflects a broader strategy to cultivate emerging technologies as new engines of economic growth, alongside fields such as embodied AI, commercial spaceflight and the low-altitude economy.
By formally recognizing BCIs as a strategic industry, China is accelerating the transition from research-stage innovation to market-ready products and services.
Private Companies Driving Innovation
A defining feature of China’s BCI development is the dominant role of private enterprises.
Companies like BrainCo are not only conducting research but also actively commercializing technologies across multiple sectors. Their applications now span:
- medical rehabilitation
- assistive devices for people with disabilities
- humanoid robotics
- industrial AI systems
This commercialization is helping bridge the gap between scientific research and large-scale deployment.
Industry data suggests that private enterprises account for the majority of China’s technological innovation output, as well as most high-tech firms in the country’s digital economy and advanced manufacturing sectors.
In this ecosystem, companies are encouraged to experiment, scale quickly, and integrate technologies into real-world applications.
Expanding Application Scenarios
Beyond healthcare and robotics, BCIs are also beginning to appear in broader commercial environments.
In China’s expanding embodied AI ecosystem, robotic systems equipped with advanced sensing and control technologies are being deployed in:
- commercial buildings
- cultural and tourism sites
- industrial parks
- retail environments
For example, robotic security systems — including AI-powered robotic dogs — are already being used in some large facilities to patrol predefined routes, detect anomalies, and support security operations.
These developments reflect a broader trend: intelligent systems are moving from isolated pilot projects into scalable infrastructure.
The Rise of Embodied Intelligence
A key direction in China’s BCI development is its integration with embodied artificial intelligence — systems that combine perception, cognition, and physical interaction.
In this model, brain-computer interfaces are not standalone technologies but part of a larger ecosystem that includes:
- robotics
- sensor networks
- machine learning models
- human–machine interaction systems
The goal is to create machines that can interpret intent, respond to human signals, and operate more naturally in shared environments.
This convergence is increasingly seen as a foundation for next-generation intelligent systems.
Challenges Ahead
Despite rapid progress, the industry still faces several challenges.
One major issue is standardization. As multiple companies develop proprietary systems, ensuring compatibility and interoperability remains difficult.
Another challenge is scalability. While pilot applications are expanding, large-scale deployment still depends on improvements in hardware reliability, data quality and regulatory frameworks.
Finally, ethical and safety considerations around brain signal interpretation and human–machine interaction will become increasingly important as the technology matures.
From Frontier Science to Emerging Industry
China’s development of brain-computer interfaces illustrates a broader transformation in how advanced technologies are brought to market.
Rather than remaining confined to research institutions, BCIs are being actively integrated into industrial strategies, commercial products and public service systems.
What is emerging is not just a new category of medical devices, but a broader industrial ecosystem that links neuroscience, artificial intelligence and robotics.
As policy support strengthens and private-sector innovation accelerates, brain-computer interfaces in China are moving steadily from frontier science toward a structured, scalable industry.
And in that transition, they are beginning to redefine how humans and machines interact.